Saxenda is indicated as an adjunct to a low-calorie diet and increased physical activity for long-term use in order to correct body weight in adult patients with BMI: ≥30 kg / m2 (obesity) or ≥27 kg / m2 to <30 kg / m2 (excessive body weight) in the presence of at least one concomitant disease associated with overweight, such as prediabetes, type 2 diabetes mellitus, arterial hypertension, dyslipidemia or obstructive sleep apnea syndrome